ChitogenX (XCNQ:CHGX) Net Income From Continuing Operations : C$-1.55 Mil (TTM As of Jan. 2024)

View and export this data going back to 2017. Start your Free Trial

What is ChitogenX Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. ChitogenX's net income from continuing operations for the three months ended in Jan. 2024 was C$-0.46 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Jan. 2024 was C$-1.55 Mil.

ChitogenX Net Income From Continuing Operations Historical Data

The historical data trend for ChitogenX's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ChitogenX Net Income From Continuing Operations Chart

ChitogenX Annual Data

Trend

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

Net Income From Continuing Operations

Get a 7-Day Free Trial

-2.49

-3.77

-4.92

-6.23

-1.55

ChitogenX Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Net Income From Continuing Operations	Get a 7-Day Free Trial															-2.16	0.10	-0.41	-0.78	-0.46

ChitogenX Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.55 Mil.

ChitogenX (XCNQ:CHGX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ChitogenX Inc (XCNQ:CHGX) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

CHNXF:USA

Address

16667 Hymus Boulevard, Kirkland, Montreal, QC, CAN, H9H 4R9

Website

https://www.chitogenx.com

ChitogenX Inc is a clinical-stage biotech company. It operates in one segment, which is the development of novel therapeutic soft tissue repair technologies.

ChitogenX (XCNQ:CHGX) Headlines

From GuruFocus

Top 5 4th Quarter Trades of Colorado Capital Management, Inc.

By GuruFocus Research GuruFocus Editor • 01-18-2023

AXS Investments Acquires Industry's First-Ever Certified Carbon-Neutral ETF (CHGX) Expanding Its ETF and ESG Lineup

By PRNewswire PRNewswire • 03-21-2022

Top 5 3rd Quarter Trades of Colorado Capital Management, Inc.

By GuruFocus Research GuruFocus Editor • 10-19-2022

IMPACTfolio, LLC Buys 3, Sells 2 in 2nd Quarter

By GuruFocus Research GuruFocus Editor • 07-06-2022